The purpose of this activity is to increase access to and sustainability of quality TB diagnosis, treatment and prevention services through the effective linkages to the health system; engagement of…

This Cooperative Agreement award, valued at $4,003,313.00, was issued by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The purpose of this 5-year award, running from October 2024 to September 2029, is to increase access to and sustainability of quality tuberculosis (TB) diagnosis, treatment, and prevention services in Cambodia through three key objectives: 1) Effective linkages to the healthcare system, 2) Engagement of communities, health facilities, and the private sector, and 3) Improved data collection and use through expansion of the TB information system. The award recipient is the Khmer HIV/AIDS NGO Alliance (Khana), a non-profit organization based in Phnom Penh, Cambodia, which has demonstrated significant capability in implementing healthcare interventions through previous USAID grants.

The purpose of this activity is to increase access to and sustainability of quality TB diagnosis, treatment and prevention services through the effective linkages to the health system; engagement of communities, health facilities, and the private sector; and improved data collection and use through sustainable expansion of the TB information system; in order to maximize health outcomes among cambodians, including vulnerable populations.